Technology | February 13, 2013
FDA Clears Planmed Extremity CT Scanner

February 13, 2013 — Planmed Verity is designed to find subtle extremity fractures during the first visit to the clinic — the types of fractures that have most commonly been missed when only using 2-D radiographs. Planmed Verity Extremity Scanner is a unique solution to the problem; it provides fast 3-D imaging at the point of care. It is intended for pre- and postoperative imaging, and it has better resolution and patient adaptability and uses a significantly lower dose of radiation than full-body computed tomography (CT). Unlike any other 3-D imaging device, Planmed Verity also allows for weight-bearing imaging of the extremities.

As a dedicated extremity scanner, Planmed Verity adapts to the patient with anatomy-specific imaging programs, movements and carbon-fiber positioning trays. Easily adjustable, soft surfaced gantry and motorized positioning help in finding a comfortable position for various examination procedures. The adjustable user interfaces and efficient all-in-one workflow are also designed to maximize the operator's soothing presence for the patient.

"Planmed Verity is the first and only CT system in the world that can image seated, supine and standing patients. We are excited that this innovative, low dose orthopedic imaging system is now available also in the U.S. We are confident that it will be well received," says Vesa Mattila, vice president of Planmed Oy.

Planmed's products are well known for their design and user ergonomics. The U.S. subsidiary Planmed USA Inc. located in Roselle, Ill., is responsible for sales, marketing and tech support for Planmed products in North America. "We are very pleased to extend our imaging equipment line to orthopedic imaging. Many of our customers have been looking forward to this clearance," says Chris Oldham, director of sales of Planmed USA Inc.

Planmed Verity has the CE mark and thus, is available for sale in Europe and many other countries where the CE certificate permits sales. In the United States, Planmed Verity has been in clinical test use at the Massachusetts General Hospital in Boston.

Planmed Verity will be on display at the American Association of Orthopedic Surgeons (AAOS) meeting starting on March 19, 2013 in Chicago.

For more information: www.planmed.com


Related Content

News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
Subscribe Now